1
|
Pequignot M, Provost A, Sallé S, Menasche M, Saule S, Jaïs JP, Abitbol M. The retinal pigment epithelium undergoes massive apoptosis during early differentiation and pigmentation of the optic cup. Mol Vis 2011; 17:989-96. [PMID: 21541273 PMCID: PMC3084227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2010] [Accepted: 04/17/2011] [Indexed: 11/21/2022] Open
Abstract
PURPOSE The aim of our work was to study apoptosis during the development of the retinal pigment epithelium (RPE) in mice between embryonic day (E) 10.5 and E12.5 and to examine a possible link between apoptosis and pigmentation. METHODS We collected mouse embryos at E10.5, E11.5, and E12.5 and labeled apoptotic cells in 5-µm paraffin sections, using the terminal deoxynucleotidyl transferase dUTP nick end labeling technique. We counted the total number of cells and the number of apoptotic cells in the early developing RPE and calculated the percentage of apoptosis at each stage. RESULTS In the C57BL/6J mouse, 17% of the RPE cells were apoptotic at E10.5 compared to 0.9% at E12.5. At E11.5, three-quarters of the RPE cells began to pigment, and apoptotic cells were located mostly in the nonpigmented part. In contrast, in the BALB/c mouse (tyrosinase-deficient) and pJ mouse (carrying mutations in the p gene) hypopigmented strains, the RPE contained significantly fewer apoptotic cells (7.5% and 10.1%, respectively) at E10.5 than controls. Subsequently at E11.5 and E12.5, the two hypopigmented strains displayed different apoptotic patterns; the BALB/c RPE had a similar percentage of apoptotic cells to controls (1.5% and 1.1%, respectively, for BALB/c versus 3.0% and 0.9%, respectively, for C57BL/6J), whereas the pJ RPE contained significantly more apoptosis (7.5% and 3.5%, respectively). Overall we observed differences in the evolution of the relative total number of RPE cells between the three strains. CONCLUSIONS Apoptosis is a main event during the first stages of normal RPE development, indicating an essential role during RPE differentiation. Moreover, the early apoptotic pattern and possibly the whole early development of the RPE is different between hypopigmented and pigmented strains, as well as between BALB/c and pJ mice. This suggests the existence of regulatory and developmental differences with a more complex origin than just differing pigmentation levels.
Collapse
Affiliation(s)
- M.O. Pequignot
- UNIVERSITE PARIS DESCARTES, CERTO, EA # MRES 2502, Faculté de Médecine PARIS DESCARTES - site Necker, Paris, France and AP-HP, Department of Ophthalmology, CHU NECKER-ENFANTS MALADES, Paris, France,Inserm U1051, Institute for Neurosciences of Montpellier, Montpellier, France
| | - A.C. Provost
- UNIVERSITE PARIS DESCARTES, CERTO, EA # MRES 2502, Faculté de Médecine PARIS DESCARTES - site Necker, Paris, France and AP-HP, Department of Ophthalmology, CHU NECKER-ENFANTS MALADES, Paris, France
| | - S. Sallé
- UNIVERSITE PARIS DESCARTES, CERTO, EA # MRES 2502, Faculté de Médecine PARIS DESCARTES - site Necker, Paris, France and AP-HP, Department of Ophthalmology, CHU NECKER-ENFANTS MALADES, Paris, France
| | - M. Menasche
- UNIVERSITE PARIS DESCARTES, CERTO, EA # MRES 2502, Faculté de Médecine PARIS DESCARTES - site Necker, Paris, France and AP-HP, Department of Ophthalmology, CHU NECKER-ENFANTS MALADES, Paris, France
| | - S. Saule
- CNRS, UMR 146, Institut Curie, Orsay, France
| | - J-P. Jaïs
- Service de Biostatistiques et d’Informatique médicale, Hôpital Necker, Paris, France
| | - M. Abitbol
- UNIVERSITE PARIS DESCARTES, CERTO, EA # MRES 2502, Faculté de Médecine PARIS DESCARTES - site Necker, Paris, France and AP-HP, Department of Ophthalmology, CHU NECKER-ENFANTS MALADES, Paris, France
| |
Collapse
|
2
|
Quentien MH, Vieira V, Menasche M, Dufier JL, Herman JP, Enjalbert A, Abitbol M, Brue T. Truncation of PITX2 differentially affects its activity on physiological targets. J Mol Endocrinol 2011; 46:9-19. [PMID: 20978111 DOI: 10.1677/jme-10-0063] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The bicoid-like transcription factor PITX2 has been previously described to interact with the pituitary-specific POU homeodomain factor POU1F1 (human ortholog of PIT-1) to achieve cell-specific expression of prolactin (PRL) and GH in pituitary somatolactotroph cells. In this work, we have investigated the functional properties of three PITX2 mutants reported in Axenfeld-Rieger syndrome patients relative to the regulation of these genes, using reporter genes under the control of human PRL (hPRL), hGH, or POU1F1 promoters transfected in nonpituitary and pituitary cell lines. Among the three mutations studied, Y167X and E101X introduce a premature stop codon, and F104L leads to an amino acid substitution. While PITX2(E101X) is not expressed in the cells following transfection, and PITX2(F104L) is functionally inactive, the PITX2(Y167X) mutant keeps its DNA-binding capacity and displays a markedly enhanced activation of the hPRL and POU1F1 promoters, but not of the hGH promoter. Y167X is the first mutation of PITX2 described to result in a differential effect on the activation of its different physiological targets, hPRL and POU1F1 on one hand and hGH on the other hand. The differential effect of the Y167X mutation might be linked to an interaction of PITX2 with different transcription factors or cofactors when bound to the hPRL and POU1F1 or the hGH promoters. These results might form the basis for the identification of the PITX2 protein complex necessary for the differential GH or PRL expression.
Collapse
Affiliation(s)
- Marie-Hélène Quentien
- Faculté de Médecine Secteur Nord, Université de la Méditerranée, Centre de Recherche en Neurobiologie et Neurophysiologie de Marseille, UMR6231, CS 80011, 13344 Marseille Cedex 15, France
| | | | | | | | | | | | | | | |
Collapse
|
3
|
Jaliffa C, Ameqrane I, Dansault A, Leemput J, Vieira V, Lacassagne E, Provost A, Bigot K, Masson C, Menasche M, Abitbol M. Sirt1 involvement in rd10 mouse retinal degeneration. Invest Ophthalmol Vis Sci 2009; 50:3562-72. [PMID: 19407027 DOI: 10.1167/iovs.08-2817] [Citation(s) in RCA: 60] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
PURPOSE Sirtuin1 (Sirt1) is an NAD(+)-dependent deacetylase involved in development, cell survival, stress resistance, energy metabolism, and aging. It is expressed in the mammalian central nervous system (CNS) and is activated during processes associated with neuroprotection. The retinal degeneration 10 (rd10) mouse model of retinitis pigmentosa (RP) was used to investigate the possible role of Sirt1 in this type of retinal degeneration. METHODS Eyes from control and rd10 mice were used. Sirt1 mRNA was detected by in situ hybridization, and its abundance was estimated by semiquantitative RT-PCR. The presence of Sirt1 protein was investigated by immunohistofluorescence and Western blot analysis. The apoptosis of photoreceptor cells was analyzed by terminal dUTP transferase nick-end labeling (TUNEL). Immunolabeling for Sirt1, apoptosis-inducing factor (Aif), and caspase-12 (Casp-12) was performed on retinal tissue sections. RESULTS Sirt1 mRNA and immunoreactivity were observed in normal adult mouse eyes. In the control retina, Sirt1 was immunolocalized mostly to the nucleus. In rd10 mice with retinal degeneration, changes in Sirt1 immunolabeling were observed only in the retinal outer nuclear layer (ONL). The pathologic pattern of Sirt1 immunoreactivity correlated with the start of retinal degeneration in rd10 mice. CONCLUSIONS The results suggest a link between Sirt1 production and retinal degeneration in rd10 mice. The anti-apoptotic, neuroprotective role of Sirt1 in the mouse retina is based on the involvement of Sirt1 in double DNA strand-break repair mechanisms and in maintaining energy homeostasis in photoreceptor cells. The results suggest that the neuroprotective properties of Sirt1 may gradually weaken in rd10 mouse photoreceptor cells.
Collapse
Affiliation(s)
- Carolina Jaliffa
- Université Paris-Descartes, Faculté de Médecine Paris-Descartes-site Necker, EA 2502 CERTO (Center de Recherches Thérapeutiques en Ophtalmologie), AP-HP (Assistance Publique-Hôpitaux de Paris), Paris, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Provost AC, Vede L, Bigot K, Keller N, Tailleux A, Jai¨s JP, Savoldelli M, Ameqrane I, Lacassagne E, Legeais JM, Staels B, Menasche M, Mallat Z, Behar-Cohen F, Abitbol M. Morphologic and Electroretinographic Phenotype of SR-BI Knockout Mice after a Long-Term Atherogenic Diet. ACTA ACUST UNITED AC 2009; 50:3931-42. [DOI: 10.1167/iovs.08-2527] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- Alexandra C. Provost
- From the Universite´ Paris-Descartes, Faculte´ de Me´decine Paris-Descartes-site Necker, Centre de Recherche The´rapeutique en Ophtalmologie, EA 2502 CERTO (Center de Recherches The´rapeutiques en Ophtalmologie), AP-HP (Assistance Publique-Ho^pitaux de Pa
| | - Leonie Vede
- From the Universite´ Paris-Descartes, Faculte´ de Me´decine Paris-Descartes-site Necker, Centre de Recherche The´rapeutique en Ophtalmologie, EA 2502 CERTO (Center de Recherches The´rapeutiques en Ophtalmologie), AP-HP (Assistance Publique-Ho^pitaux de Pa
| | - Karine Bigot
- From the Universite´ Paris-Descartes, Faculte´ de Me´decine Paris-Descartes-site Necker, Centre de Recherche The´rapeutique en Ophtalmologie, EA 2502 CERTO (Center de Recherches The´rapeutiques en Ophtalmologie), AP-HP (Assistance Publique-Ho^pitaux de Pa
| | - Nicole Keller
- Centre de Recherche des Cordeliers, UMR 872, Institut National de la Sante´ et de la Recherche Me´dicale (INSERM), Paris, France; the
| | - Anne Tailleux
- Atherosclerosis Department, Institut Pasteur de Lille and Faculty of Pharmacy, Unit 545, INSERM, Lille, France; the
| | | | | | - Ilhame Ameqrane
- From the Universite´ Paris-Descartes, Faculte´ de Me´decine Paris-Descartes-site Necker, Centre de Recherche The´rapeutique en Ophtalmologie, EA 2502 CERTO (Center de Recherches The´rapeutiques en Ophtalmologie), AP-HP (Assistance Publique-Ho^pitaux de Pa
| | - Emmanuelle Lacassagne
- From the Universite´ Paris-Descartes, Faculte´ de Me´decine Paris-Descartes-site Necker, Centre de Recherche The´rapeutique en Ophtalmologie, EA 2502 CERTO (Center de Recherches The´rapeutiques en Ophtalmologie), AP-HP (Assistance Publique-Ho^pitaux de Pa
| | - Jean-Marc Legeais
- Department of Ophthalmology, Ho^pital Hotel-Dieu, Paris, France; and the
| | - Bart Staels
- Atherosclerosis Department, Institut Pasteur de Lille and Faculty of Pharmacy, Unit 545, INSERM, Lille, France; the
| | - Maurice Menasche
- From the Universite´ Paris-Descartes, Faculte´ de Me´decine Paris-Descartes-site Necker, Centre de Recherche The´rapeutique en Ophtalmologie, EA 2502 CERTO (Center de Recherches The´rapeutiques en Ophtalmologie), AP-HP (Assistance Publique-Ho^pitaux de Pa
| | - Ziad Mallat
- Cardiovascular Research Center, Ho^pital Lariboisiere, Unit 689, INSERM, Paris, France
| | - Francine Behar-Cohen
- Centre de Recherche des Cordeliers, UMR 872, Institut National de la Sante´ et de la Recherche Me´dicale (INSERM), Paris, France; the
| | - Marc Abitbol
- From the Universite´ Paris-Descartes, Faculte´ de Me´decine Paris-Descartes-site Necker, Centre de Recherche The´rapeutique en Ophtalmologie, EA 2502 CERTO (Center de Recherches The´rapeutiques en Ophtalmologie), AP-HP (Assistance Publique-Ho^pitaux de Pa
| |
Collapse
|
5
|
Bigot K, Leemput J, Vacher M, Campalans A, Radicella JP, Lacassagne E, Provost A, Masson C, Menasche M, Abitbol M. Expression of 8-oxoguanine DNA glycosylase (Ogg1) in mouse retina. Mol Vis 2009; 15:1139-52. [PMID: 19503746 PMCID: PMC2690988] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2008] [Accepted: 05/27/2009] [Indexed: 10/26/2022] Open
Abstract
PURPOSE The retina is highly exposed to oxidative stress due to the high level of oxygen consumption in this tissue and its exposure to light. The main DNA base lesion generated by oxygen free radicals is 8-oxoguanine (8-oxoG). However, its presence in retinal cells and the mechanisms underlying its repair remain undetermined. METHODS 8-oxoguanine DNA glycosylase (Ogg1) gene expression and messenger localization in adult mouse ocular tissues was analyzed by RT-PCR and in situ hybridization. Using immunohistochemistry, we determined the localization of Ogg1 protein and three base excision repair (BER) enzymes: apurinic/apyrimidic endonuclease (APE1), DNA polymerase beta, and X-ray repair cross-complementation group 1 (XRCC1). Ogg1 and AP-lyase activities in the neuroretina were obtained using double-stranded oligonucleotides harboring either an 8-oxoG residue or a tetrahydrofuran. RESULTS We report here that 8-oxoG is abundant in the retina. Ogg1, the enzyme responsible for the recognition and excision of the oxidized base, is present in its active form and found mainly in ganglion cells and photoreceptor inner segments. We show that APE1 and DNA polymerase beta, two BER proteins involved in 8-oxoG repair, are also present in these cells. The cellular distribution of these proteins was similar to that of Ogg1. XRRC1 is present in both inner nuclear and ganglion cells layers; however, this protein is absent from photoreceptor inner segments. CONCLUSIONS This is the first study to demonstrate the presence of a functional 8-oxoG BER pathway in retinal neurons. The study of three BER proteins involved in 8-oxoG elimination demonstrates that XRCC1 localization differs from those of Ogg1, APE1, and DNA polymerase beta. This result suggests that the elimination of 8-oxoG is coordinated through two pathways, which differ slightly according to the cellular localization of the abnormally oxidized guanine.
Collapse
Affiliation(s)
- Karine Bigot
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie, Paris, France
| | - Julia Leemput
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie, Paris, France
| | - Monique Vacher
- Commissariat à l’Energie Atomique, Institut de Radiobiologie Cellulaire et Moléculaire, Fontenay aux Roses, France
| | - Anna Campalans
- Commissariat à l’Energie Atomique, Institut de Radiobiologie Cellulaire et Moléculaire, Fontenay aux Roses, France
| | - J. Pablo Radicella
- Commissariat à l’Energie Atomique, Institut de Radiobiologie Cellulaire et Moléculaire, Fontenay aux Roses, France
| | - Emmanuelle Lacassagne
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie, Paris, France
| | - Alexandra Provost
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie, Paris, France
| | - Christel Masson
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie, Paris, France
| | - Maurice Menasche
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie, Paris, France
| | - Marc Abitbol
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie, Paris, France,Service d’Ophtalmologie du CHU Necker-Enfants–Malades, Paris, France
| |
Collapse
|
6
|
Leemput J, Masson C, Bigot K, Errachid A, Dansault A, Provost A, Gadin S, Aoufouchi S, Menasche M, Abitbol M. ATM localization and gene expression in the adult mouse eye. Mol Vis 2009; 15:393-416. [PMID: 19234633 PMCID: PMC2645907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2008] [Accepted: 02/14/2009] [Indexed: 11/19/2022] Open
Abstract
PURPOSE High levels of metabolism and oxygen consumption in most adult murine ocular compartments, combined with exposure to light and ultraviolet (UV) radiation, are major sources of oxidative stress, causing DNA damage in ocular cells. Of all mammalian body cells, photoreceptor cells consume the largest amount of oxygen and generate the highest levels of oxidative damage. The accumulation of such damage throughout life is a major factor of aging tissues. Several multiprotein complexes have recently been identified as the major sensors and mediators involved in the maintenance of DNA integrity. The activity of these complexes initially seemed to be restricted to dividing cells, given their ultimate role in major cell cycle checkpoints. However, it was later established that they are also active in post-mitotic cells. Recent findings demonstrate that the DNA damage response (DDR) is essential for the development, maintenance, and normal functioning of the adult central nervous system. One major molecular factor in the DDR is the protein, ataxia telangiectasia mutated (ATM). It is required for the rapid induction of cellular responses to DNA double-strand breaks. These cytotoxic DNA lesions may be caused by oxidative damage. To understand how ATM prevents oxidative stress and participates in the maintenance of genomic integrity and cell viability of the adult retina, we determined the ATM expression patterns and studied its localization in the adult mouse eye. METHODS Atm gene expression was analyzed by RT-PCR experiments and its localization by in situ hybridization on adult mouse ocular and cerebellar tissue sections. ATM protein expression was determined by western blot analysis of proteins homogenates extracted from several mouse tissues and its localization by immunohistochemistry experiments performed on adult mouse ocular and cerebellar tissue sections. In addition, subcellular localization was realized by confocal microscopy imaging of ocular tissue sections, with a special focus on retinal cells. RESULTS Using RT-PCR, we detected a band of the expected size, with its sequence matching the amplified Atm cDNA sequence. Atm mRNA was detected in most cell bodies of the adult mouse eye by in situ hybridization of ocular tissue sections with specific digoxigenin-labeled PCR-amplified cDNA probes. Western blotting with different specific antibodies revealed bands corresponding to the expected sizes of ATM and its active forms (ATMp). These bands were not observed in the analysis of protein homogenates from Atm-deficient mouse tissues. ATM immunoreactivity was detected in the nucleus of all adult mice retinal cells and in most non-neuronal ocular cell types. The active phosphorylated form of ATM was also present in the retina as well as in non-neuronal cells of the adult mouse eye. However, its subcellular localization differed as a function of the cell type examined. A major finding of this study was that ATMp immunostaining in photoreceptor cells was exclusively in the cytoplasm, whereas ATM immunostaining was only in the nucleus of these cells. Furthermore, the specific and distinct ATM and ATMp immunolabeling patterns in photoreceptor cells were identical to those observed in the adult mouse cerebellar granule cells. CONCLUSIONS We report the expression profile of Atm gene and protein in the adult mouse eye. In particular, we observed a difference between the localization patterns of the active and inactive forms of ATM in photoreceptor cells. These localization patterns suggest that ATM and its phosphorylated activated form may be involved in both the protection of cells from oxidative damage and the maintenance of ocular cell structure and function. The protection mechanisms mediated by the two forms of ATM appear to be particularly important in maintaining photoreceptor integrity.
Collapse
Affiliation(s)
- Julia Leemput
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, Paris, France
| | - Christel Masson
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, Paris, France
| | - Karine Bigot
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, Paris, France
| | - Abdelmounaim Errachid
- Université Paris-Descartes, Plateforme d’imagerie Cellulaire de la Faculté de Médecine Paris-Descartes-site Necker, Paris, France
| | - Anouk Dansault
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, Paris, France
| | - Alexandra Provost
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, Paris, France
| | - Stéphanie Gadin
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, Paris, France
| | - Said Aoufouchi
- Université Paris-Descartes, Développement du Système Immunitaire, INSERM U783, Faculté de Médecine Paris-Descartes-site Necker, Paris, France
| | - Maurice Menasche
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, Paris, France
| | - Marc Abitbol
- Université Paris-Descartes, CERTO, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, Paris, France
| |
Collapse
|
7
|
Raji B, Dansault A, Vieira V, de la Houssaye G, Lacassagne E, Kobetz A, Arbogast L, Dufier J, Blumer J, Menasche M, Abitbol M. Analysis of partner of inscuteable (mPins) expression in the developing mouse eye. Mol Vis 2008; 14:2575-96. [PMID: 19122831 PMCID: PMC2613078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2008] [Accepted: 12/22/2008] [Indexed: 11/06/2022] Open
Abstract
PURPOSE Asymmetric cell division (ACD) is the fundamental mechanism underlying the generation of cellular diversity in invertebrates and vertebrates. During Drosophila neuroblast division, this process involves stabilization of the apical complex and interaction between the Inscuteable (Insc) and Partner of inscuteable (Pins) proteins. Both cell-intrinsic factors and cell-cell interactions seem to contribute to cell fate decisions in the retina. The Pins protein is known to play a major role in the asymmetric segregation of cell fate determinants during development of the central nervous system in general, but its role in asymmetric cell divisions and retinoblast cell fate has never been explored. The primary aim of this study was to determine the spatial distribution and time course of mouse homolog of Drosophila Partner of Inscuteable (mPins) expression in the developing and adult mouse eye. METHODS The expression pattern of mPins was studied in the mouse eye from embryonic (E) stage E11.5 until adulthood, by semiquantitative RT-PCR, in situ hybridization, and immunohistochemistry. In addition, variations in mRNA and protein levels for mPins were analyzed in the developing postnatal and adult lens, by semiquantitative RT-PCR, western blot analysis, in situ hybridization, and immunohistochemistry. RESULTS We detected mPins mRNA at early stages of mouse embryonic eye development, particularly in the neuroblastic layer. In early postnatal development, mPins mRNA was still detected in the neuroblastic layer, but also began to be detectable in the ganglion cell layer. Thereafter, mPins mRNA was found throughout the retina. This pattern was maintained in differentiated adult retina. Immunohistochemical studies showed that mPins protein was present in the neuroblastic layer and the ganglion cell layer during the early stages of postnatal retinal development. At these stages, mPins protein was colocalized with Numb protein, a marker of the ACD. At later postnatal stages, mPins protein was present in all retinal nuclear layers and in the inner plexiform layer. It continued to be detected in these layers in the differentiated retina; the outer plexiform layer and the photoreceptor inner segments also began to display positive immunostaining for mPins. In the adult retina, mPins was also detected in the retinal pigment epithelium and choroidal melanocytes. Throughout development, mPins protein was detected in nonretinal tissues, including the cornea, ciliary body, and lens. We focused our attention on lens development and showed that mPins protein was first detected at E14.5. The most striking results obtained concerned the lens, in which mPins protein distribution switched from the anterior to the posterior region of the lens during embryonic development. Interestingly, in the postnatal and adult lens, mPins protein was detected in all lens cells and fibers. CONCLUSIONS We provide the first demonstration that mPins protein is expressed from embryonic stages until adulthood in the mouse eye. These results suggest that mPins plays important roles in eye development. This work provides preliminary evidence strongly supporting a role for mPins in the asymmetric division of retinoblasts, and in the structure and functions of adult mouse retina. However, the link between the presence of mPins in different ocular compartments and the possible occurrence of asymmetric cell divisions in these compartments remains to be clarified. Further studies are required to elucidate the in vitro and in vivo functions of mPins in the developing and adult human eye.
Collapse
Affiliation(s)
- B. Raji
- Université Paris-Descartes, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes, Equipe d’accueil n°2502 du Ministère de la Recherche et de l’Enseignement Supérieur, AP-HP, CHU Necker-Enfants Malades, Paris, France
| | - A. Dansault
- Université Paris-Descartes, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes, Equipe d’accueil n°2502 du Ministère de la Recherche et de l’Enseignement Supérieur, AP-HP, CHU Necker-Enfants Malades, Paris, France
| | - V. Vieira
- Université Paris-Descartes, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes, Equipe d’accueil n°2502 du Ministère de la Recherche et de l’Enseignement Supérieur, AP-HP, CHU Necker-Enfants Malades, Paris, France
| | - G. de la Houssaye
- Université Paris-Descartes, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes, Equipe d’accueil n°2502 du Ministère de la Recherche et de l’Enseignement Supérieur, AP-HP, CHU Necker-Enfants Malades, Paris, France
| | - E. Lacassagne
- Université Paris-Descartes, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes, Equipe d’accueil n°2502 du Ministère de la Recherche et de l’Enseignement Supérieur, AP-HP, CHU Necker-Enfants Malades, Paris, France
| | - A. Kobetz
- Université Paris-Descartes, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes, Equipe d’accueil n°2502 du Ministère de la Recherche et de l’Enseignement Supérieur, AP-HP, CHU Necker-Enfants Malades, Paris, France
| | - L. Arbogast
- Université Paris-Descartes, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes, Equipe d’accueil n°2502 du Ministère de la Recherche et de l’Enseignement Supérieur, AP-HP, CHU Necker-Enfants Malades, Paris, France
| | - J.L. Dufier
- Université Paris-Descartes, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes, Equipe d’accueil n°2502 du Ministère de la Recherche et de l’Enseignement Supérieur, AP-HP, CHU Necker-Enfants Malades, Paris, France,Service d'Ophtalmologie, Hôpital Necker-Enfants Malades, Paris, France
| | - J.B. Blumer
- Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC
| | - M. Menasche
- Université Paris-Descartes, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes, Equipe d’accueil n°2502 du Ministère de la Recherche et de l’Enseignement Supérieur, AP-HP, CHU Necker-Enfants Malades, Paris, France
| | - M. Abitbol
- Université Paris-Descartes, Centre de Recherche Thérapeutique en Ophtalmologie de la Faculté de Médecine Paris-Descartes, Equipe d’accueil n°2502 du Ministère de la Recherche et de l’Enseignement Supérieur, AP-HP, CHU Necker-Enfants Malades, Paris, France,Service d'Ophtalmologie, Hôpital Necker-Enfants Malades, Paris, France
| |
Collapse
|
8
|
Vieira V, de la Houssaye G, Lacassagne E, Dufier J, Jaïs J, Beermann F, Menasche M, Abitbol M. Differential regulation of Dlg1, Scrib, and Lgl1 expression in a transgenic mouse model of ocular cancer. Mol Vis 2008; 14:2390-403. [PMID: 19098995 PMCID: PMC2605424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2008] [Accepted: 12/10/2008] [Indexed: 11/30/2022] Open
Abstract
PURPOSE Discs large (dlg), scribble (scrib), and lethal giant larvae (lgl) are major suppressor genes in Drosophila melanogaster. They encode proteins that regulate cell polarity and cell proliferation in Drosophila and mammals. However, their basic oncogenic roles have not yet been established in mouse epithelial ocular cancer. We evaluated the potential implication of these proteins in tumorigenesis of adenocarcinomas originating from the retinal pigmented epithelium of the Trp1/Tag transgenic mouse model. We examined the changes in the distribution and levels of these proteins in mouse ocular tissues from the Trp1/Tag mouse model. METHODS The expression patterns of theses genes and their corresponding proteins in normal mouse ocular tissues were studied by in situ hibridization and immunohistofluorescence experiments. In addition, variations in mRNA and proteins levels and protein distributions for Dlg1, Scrib, and Lgl1 were analyzed in the ocular tissues from Trp1/Tag transgenic mouse model by reverse transcription polymerase chain reaction (RT-PCR), western blot analysis, and immunohistofluorescence. RESULTS We found that mouse Dlg1, Scrib, and Lgl1 are widely distributed in normal ocular tissues, particularly in retinal neurons. We found that the three proteins are mislocalized in retinal layers during ocular carcinogenesis. These mislocalizations were correlated to the early dysplastic stages of ocular tumorigenesis. Additionally, the mislocalization of each protein was associated with its downregulation. Decreased levels of these proteins may be considered as late-stage markers of the disease but also as markers of the invasive stage of this cancerous process. This downregulation may be involved in epithelial-mesenchymal transition in this mouse ocular tumoral model. This would be consistent with the downregulation of E-cadherin and upregulation of N-cadherin expression observed in this model. CONCLUSIONS This is the first study to demonstrate the involvement of Dlg1, Scrib, and Lgl1 in a mouse with ocular adenocarcinoma and the simultaneous involvement of these proteins in the same cancer. Our results indicate that both the mislocalization and downregulation of these proteins may be involved together in ocular carcinogenesis.
Collapse
Affiliation(s)
- V. Vieira
- Université Paris-Descartes, CERTO, Centre de Recherches Thérapeutiques en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, EA n°2502 du Ministère de la Recherche, AP-HP, Paris, France
| | - G. de la Houssaye
- Université Paris-Descartes, CERTO, Centre de Recherches Thérapeutiques en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, EA n°2502 du Ministère de la Recherche, AP-HP, Paris, France
| | - E. Lacassagne
- Université Paris-Descartes, CERTO, Centre de Recherches Thérapeutiques en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, EA n°2502 du Ministère de la Recherche, AP-HP, Paris, France
| | - J.L. Dufier
- Université Paris-Descartes, CERTO, Centre de Recherches Thérapeutiques en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, EA n°2502 du Ministère de la Recherche, AP-HP, Paris, France,Service d’Ophtalmologie, Hôpital Necker Enfants Malades, Paris, France
| | - J.P. Jaïs
- Université Paris-Descartes, Faculté de Médecine Paris-Descartes, EA n°4067 du Ministère de la Recherche, AP-HP, Service de Biostastistiques et Bioinformatique du CHU Necker-Enfants-Malades, Paris, France
| | - F. Beermann
- Swiss Institute for Experimental Cancer Research (ISREC), Epalinges, Switzerland
| | - M. Menasche
- Université Paris-Descartes, CERTO, Centre de Recherches Thérapeutiques en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, EA n°2502 du Ministère de la Recherche, AP-HP, Paris, France
| | - M. Abitbol
- Université Paris-Descartes, CERTO, Centre de Recherches Thérapeutiques en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, EA n°2502 du Ministère de la Recherche, AP-HP, Paris, France,Service d’Ophtalmologie, Hôpital Necker Enfants Malades, Paris, France
| |
Collapse
|
9
|
Abitbol M, Roche O, Bieche I, Bigot K, Perez E, Laurendeau I, Jais J, Menasche M, Vidaud M, Dufier J, Lelong D. 033 Un nouveau modèle murin d’amaurose unilatérale d’origine purement vasculaire. J Fr Ophtalmol 2008. [DOI: 10.1016/s0181-5512(08)70627-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
10
|
Lelong DC, Bieche I, Perez E, Bigot K, Leemput J, Laurendeau I, Vidaud M, Jais JP, Menasche M, Abitbol M. Novel mouse model of monocular amaurosis fugax. Stroke 2007; 38:3237-44. [PMID: 17975099 DOI: 10.1161/strokeaha.107.499319] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE Retinal ischemia is a major cause of visual impairment and is associated with a high risk of subsequent ischemic stroke. The retina and its projections are easily accessible for experimental procedures and functional evaluation. We created and characterized a mouse model of global and transient retinal ischemia and provide a comprehensive chronologic profile of some genes that display altered expression during ischemia. METHODS Ischemia and reperfusion were assessed by observing flat-mounted retinas after systemic fluorescein injection. The temporal pattern of gene expression modulation was evaluated by quantitative reverse transcription-polymerase chain reaction from the occurrence of unilateral 30-minute pterygopalatine artery occlusion until 4 weeks after reperfusion. Electroretinograms evaluated functional sequelae 4 weeks after the ischemic episode and were correlated with histologic lesions. RESULTS This model is the first to reproduce the features of transient monocular amaurosis fugax resulting from ophthalmic artery occlusion. The histologic structure was roughly conserved, but functional lesions affected ganglion cells, inner nuclear layer cells, and photoreceptor cells. We observed an early and strong upregulation of c-fos, c-jun, Cox-2, Hsp70, and Gadd34 gene expression and a late decrease in Hsp70 transcript levels. CONCLUSIONS A murine model of transient retinal ischemia was successfully developed that exhibited the characteristic upregulation of immediate-early genes and persistent functional deficits. The model should prove useful for investigating mechanisms of injury in genetically altered mice and for testing novel neuroprotective drugs.
Collapse
Affiliation(s)
- Dominique Claude Lelong
- Centre de Recherche Thérapeutique en Ophtalmologie-CERTO, Faculté de Médecine Paris-Descartes, Site Necker, 156 rue de Vaugirard, 75015 Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Raji B, Dansault A, Leemput J, de la Houssaye G, Vieira V, Kobetz A, Arbogast L, Masson C, Menasche M, Abitbol M. The RNA-binding protein Musashi-1 is produced in the developing and adult mouse eye. Mol Vis 2007; 13:1412-27. [PMID: 17768378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/17/2023] Open
Abstract
PURPOSE Musashi-1 (Msi1) is an RNA-binding protein produced in various types of stem cells including neural stem/progenitor cells and astroglial progenitor cells in the vertebrate central nervous system. Other RNA-binding proteins such as Pumilio-1, Pumilio-2, Staufen-1, and Staufen-2 have been characterized as potential markers of several types of stem or progenitor cells. We investigated the involvement of Msi1 in mouse eye development and adult mouse eye functions by analyzing the profile of Msi1 production in all ocular structures during development and adulthood. METHODS We studied Msi1 production by in situ hybridization and immunohistochemistry of ocular tissue sections and by semi-quantitative RT-PCR and western blot analysis from the embryonic stage of 12.5 days post coitum (E12.5 dpc) when the first retinal ganglion cells (RGCs) begin to appear to the adult stage when all retinal cell types are present. RESULTS Msi1 mRNA was present at all studied stages of eye development. Msi1 protein was detected in the primitive neuroblastic layer (NbL), the ganglion cell layer (GCL), and in all major differentiated neurons of postnatal developing and adult retinae. During postnatal developing stages, faint diffuse Msi1 protein staining is converted to a more specific distribution once mouse retina is fully differentiated. The most striking result of our study concerns the large amounts of Msi1 protein and mRNA in several unexpected sites of adult mouse eyes including the corneal epithelium and endothelium, stromal keratocytes, progenitor cells of the limbus, equatorial lens stem cells, differentiated lens epithelial cells, and differentiating lens fibers. Msi1 was also found in the pigmented and nonpigmented cells of the ciliary processes, the melanocytes of the ciliary body, the retinal pigment epithelium, differentiated retinal neurons, and most probably in the retinal glial cells such as Müller glial cells, astrocytes, and the oligodendocytes surrounding the axons of the optic nerve. Msi1 expression was detected in the outer plexiform layer, the inner plexiform layer, and the nerve fiber layer of fully differentiated adult retina. CONCLUSIONS We provide here the first demonstration that the RNA-binding protein, Msi1, is produced in mouse eyes from embryonic stages until adulthood. The relationship between the presence of Msi1 in developing ocular compartments and the possible stem/progenitor cell characteristics of these compartments remains unclear. Finally, the expression of Msi1 in several different cell types in the adult eye is extremely intriguing and should lead to further attempts to unravel the role of Msi1 in cellular and subcellular RNA metabolism and in the control of translational processes in adult eye cells particularly in adult neuronal dendrites, axons, and synapses.
Collapse
Affiliation(s)
- B Raji
- CERTO, Centre de Recherche Thérapeutique en Ophtalmologie, Faculté de Medecine Paris-Descartes-site Necker, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Vieira V, de la Houssaye G, Dansault A, Perez E, Roche O, Dufier JL, Marsac C, Menasche M, Abitbol M. Novel human pathological mutations. Gene symbol: FZD4. Disease: familial exudative vitreoretinopathy. Hum Genet 2007; 121:650. [PMID: 17879448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/17/2023]
|
13
|
Dansault A, David G, Schwartz C, Jaliffa C, Vieira V, de la Houssaye G, Bigot K, Catin F, Tattu L, Chopin C, Halimi P, Roche O, Van Regemorter N, Munier F, Schorderet D, Dufier JL, Marsac C, Ricquier D, Menasche M, Penfornis A, Abitbol M. Three new PAX6 mutations including one causing an unusual ophthalmic phenotype associated with neurodevelopmental abnormalities. Mol Vis 2007; 13:511-23. [PMID: 17417613 PMCID: PMC2649307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE The PAX6 gene was first described as a candidate for human aniridia. However, PAX6 expression is not restricted to the eye and it appears to be crucial for brain development. We studied PAX6 mutations in a large spectrum of patients who presented with aniridia phenotypes, Peters' anomaly, and anterior segment malformations associated or not with neurological anomalies. METHODS Patients and related families were ophthalmologically phenotyped, and in some cases neurologically and endocrinologically examined. We screened the PAX6 gene by direct sequencing in three groups of patients: those affected by aniridia; those with diverse ocular manifestations; and those with Peters' anomaly. Two mutations were investigated by generating crystallographic representations of the amino acid changes. RESULTS Three novel heterozygous mutations affecting three unrelated families were identified: the g.572T>C nucleotide change, located in exon 5, and corresponding to the Leucine 46 Proline amino-acid mutation (L46P); the g.655A>G nucleotide change, located in exon 6, and corresponding to the Serine 74 Glycine amino-acid mutation (S74G); and the nucleotide deletion 579delG del, located in exon 6, which induces a frameshift mutation leading to a stop codon (V48fsX53). The L46P mutation was identified in affected patients presenting bilateral microphthalmia, cataracts, and nystagmus. The S74G mutation was found in a large family that had congenital ocular abnormalities, diverse neurological manifestations, and variable cognitive impairments. The 579delG deletion (V48fsX53) caused in the affected members of the same family bilateral aniridia associated with congenital cataract, foveal hypolasia, and nystagmus. We also detected a novel intronic nucleotide change, IVS2+9G>A (very likely a mutation) in an apparently isolated patient affected by a complex ocular phenotype, characterized primarily by a bilateral microphthalmia. Whether this nucleotide change is indeed pathogenic remains to be demonstrated. Two previously known heterozygous mutations of the PAX6 gene sequence were also detected in patients affected by aniridia: a de novo previously known nucleotide change, g.972C>T (Q179X), in exon 8, leading to a stop codon and a heterozygous g.555C>A (C40X) recurrent nonsense mutation in exon 5. No mutations were found in patients with Peters' anomaly. CONCLUSIONS We identified three mutations associated with aniridia phenotypes (Q179X, C40X, and V48fsX53). The three other mutations reported here cause non-aniridia ocular phenotypes associated in some cases with neurological anomalies. The IVS2+9G>A nucleotide change was detected in a patient with a microphthalmia phenotype. The L46P mutation was detected in a family with microphthalmia, cataract, and nystagmus. This mutation is located in the DNA-binding paired-domain and the crystallographic representations of this mutation show that this mutation may affect the helix-turn-helix motif, and as a consequence the DNA-binding properties of the resulting mutated protein. Ser74 is located in the PAX6 PD linker region, essential for DNA recognition and DNA binding, and the side chain of the Ser74 contributes to DNA recognition by the linker domain through direct contacts. Crystallographic representations show that the S74G mutation results in no side chain and therefore perturbs the DNA-binding properties of PAX6. This study highlights the severity and diversity of the consequences of PAX6 mutations that appeared to result from the complexity of the PAX6 gene structure, and the numerous possibilities for DNA binding. This study emphasizes the fact that neurodevelopmental abnormalities may be caused by PAX6 mutations. The neuro-developmental abnormalities caused by PAX6 mutations are probably still overlooked in the current clinical examinations performed throughout the world in patients affected by PAX6 mutations.
Collapse
Affiliation(s)
- Anouk Dansault
- EA n 2502 du Ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, Center de Recherches Thérapeutiques en Ophtalmologie (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, Paris, France
| | - Gabriel David
- CNRS UPR 9078, Faculté de Médecine René Descartes-Site Necker, Paris, France
| | | | - Carolina Jaliffa
- EA n 2502 du Ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, Center de Recherches Thérapeutiques en Ophtalmologie (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, Paris, France
| | - Véronique Vieira
- EA n 2502 du Ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, Center de Recherches Thérapeutiques en Ophtalmologie (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, Paris, France
| | - Guillaume de la Houssaye
- EA n 2502 du Ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, Center de Recherches Thérapeutiques en Ophtalmologie (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, Paris, France
| | - Karine Bigot
- EA n 2502 du Ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, Center de Recherches Thérapeutiques en Ophtalmologie (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, Paris, France
| | - Françise Catin
- Service de Neuro-Imagerie du CHU de Besançon, Doubs, France
| | - Laurent Tattu
- Service de Neurologie du CHU de Besançon, Doubs, France
| | | | - Philippe Halimi
- Service d'Imagerie de l'Hopital Européen Georges Pompidou, Paris, France
| | - Olivier Roche
- EA n 2502 du Ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, Center de Recherches Thérapeutiques en Ophtalmologie (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, Paris, France
- Service d'Ophtalmologie, Hôpital Necker-Enfants Malades, Paris, France
| | | | | | | | - Jean-Louis Dufier
- EA n 2502 du Ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, Center de Recherches Thérapeutiques en Ophtalmologie (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, Paris, France
- Service d'Ophtalmologie, Hôpital Necker-Enfants Malades, Paris, France
| | - Cécile Marsac
- EA n 2502 du Ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, Center de Recherches Thérapeutiques en Ophtalmologie (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, Paris, France
| | - Daniel Ricquier
- CNRS UPR 9078, Faculté de Médecine René Descartes-Site Necker, Paris, France
| | - Maurice Menasche
- EA n 2502 du Ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, Center de Recherches Thérapeutiques en Ophtalmologie (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, Paris, France
| | - Alfred Penfornis
- Service d'Endocrinologie et Diabétologie du CHU de Besançon, Doubs, France
| | - Marc Abitbol
- EA n 2502 du Ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, Center de Recherches Thérapeutiques en Ophtalmologie (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, Paris, France
- Service d'Ophtalmologie, Hôpital Necker-Enfants Malades, Paris, France
| |
Collapse
|
14
|
Marchant D, Yu K, Bigot K, Roche O, Germain A, Bonneau D, Drouin-Garraud V, Schorderet DF, Munier F, Schmidt D, Le Neindre P, Marsac C, Menasche M, Dufier JL, Fischmeister R, Hartzell C, Abitbol M. New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy. J Med Genet 2007; 44:e70. [PMID: 17287362 PMCID: PMC2598027 DOI: 10.1136/jmg.2006.044511] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
PURPOSE The mutations responsible for Best vitelliform macular dystrophy (BVMD) are found in a gene called VMD2. The VMD2 gene encodes a transmembrane protein named bestrophin-1 (hBest1) which is a Ca(2+)-sensitive chloride channel. This study was performed to identify disease-specific mutations in 27 patients with BVMD. Because this disease is characterised by an alteration in Cl(-) channel function, patch clamp analysis was used to test the hypothesis that one of the VMD2 mutated variants causes the disease. METHODS Direct sequencing analysis of the 11 VMD2 exons was performed to detect new abnormal sequences. The mutant of hBest1 was expressed in HEK-293 cells and the associated Cl(-) current was examined using whole-cell patch clamp analysis. RESULTS Six new VMD2 mutations were identified, located exclusively in exons four, six and eight. One of these mutations (Q293H) was particularly severe. Patch clamp analysis of human embryonic kidney cells expressing the Q293H mutant showed that this mutant channel is non-functional. Furthermore, the Q293H mutant inhibited the function of wild-type bestrophin-1 channels in a dominant negative manner. CONCLUSIONS This study provides further support for the idea that mutations in VMD2 are a necessary factor for Best disease. However, because variable expressivity of VMD2 was observed in a family with the Q293H mutation, it is also clear that a disease-linked mutation in VMD2 is not sufficient to produce BVMD. The finding that the Q293H mutant does not form functional channels in the membrane could be explained either by disruption of channel conductance or gating mechanisms or by improper trafficking of the protein to the plasma membrane.
Collapse
Affiliation(s)
- D Marchant
- Centre de recherche thérapeutique en ophtalmologie, équipe d'accueil 2502 MENRT, Université René Descartes Paris V, Faculté de Médecine Necker-Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
de la Houssaye G, Bieche I, Roche O, Vieira V, Laurendeau I, Arbogast L, Zeghidi H, Rapp P, Halimi P, Vidaud M, Dufier JL, Menasche M, Abitbol M. Identification of the first intragenic deletion of the PITX2 gene causing an Axenfeld-Rieger Syndrome: case report. BMC Med Genet 2006; 7:82. [PMID: 17134502 PMCID: PMC1684248 DOI: 10.1186/1471-2350-7-82] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/10/2006] [Accepted: 11/29/2006] [Indexed: 11/21/2022]
Abstract
BACKGROUND Axenfeld-Rieger syndrome (ARS) is characterized by bilateral congenital abnormalities of the anterior segment of the eye associated with abnormalities of the teeth, midface, and umbilicus. Most cases of ARS are caused by mutations in the genes encoding PITX2 or FOXC1. Here we describe a family affected by a severe form of ARS. CASE PRESENTATION Two members of this family (father and daughter) presented with typical ARS and developed severe glaucoma. The ocular phenotype was much more severe in the daughter than in the father. Magnetic resonance imaging (MRI) detected an aggressive form of meningioma in the father. There was no mutation in the PITX2 gene, determined by exon screening. We identified an intragenic deletion by quantitative genomic PCR analysis and characterized this deletion in detail. CONCLUSION Our findings implicate the first intragenic deletion of the PITX2 gene in the pathogenesis of a severe form of ARS in an affected family. This study stresses the importance of a systematic search for intragenic deletions in families affected by ARS and in sporadic cases for which no mutations in the exons or introns of PITX2 have been found. The molecular genetics of some ARS pedigrees should be re-examined with enzymes that can amplify medium and large genomic fragments.
Collapse
Affiliation(s)
- Guillaume de la Houssaye
- Centre de Recherche Thérapeutique en Ophtalmologie, EA n°2502, Faculté de Médecine René Descartes, site Necker, 156 rue de Vaugirard 75730 Paris cedex 15, Université Paris V, Paris, France
| | - Ivan Bieche
- Laboratoire de Génétique Moleculaire-INSERM U745, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris V, Paris, France
| | - Olivier Roche
- Centre de Recherche Thérapeutique en Ophtalmologie, EA n°2502, Faculté de Médecine René Descartes, site Necker, 156 rue de Vaugirard 75730 Paris cedex 15, Université Paris V, Paris, France
- CHU Necker Enfants Malades, Service d'ophtalmologie, 149, rue de Sèvres 75 Paris cedex 15, France
| | - Véronique Vieira
- Centre de Recherche Thérapeutique en Ophtalmologie, EA n°2502, Faculté de Médecine René Descartes, site Necker, 156 rue de Vaugirard 75730 Paris cedex 15, Université Paris V, Paris, France
| | - Ingrid Laurendeau
- Laboratoire de Génétique Moleculaire-INSERM U745, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris V, Paris, France
| | - Laurence Arbogast
- Centre de Recherche Thérapeutique en Ophtalmologie, EA n°2502, Faculté de Médecine René Descartes, site Necker, 156 rue de Vaugirard 75730 Paris cedex 15, Université Paris V, Paris, France
| | - Hatem Zeghidi
- CHU Necker Enfants Malades, Service d'ophtalmologie, 149, rue de Sèvres 75 Paris cedex 15, France
| | - Philippe Rapp
- CHU Necker Enfants Malades, Service d'ophtalmologie, 149, rue de Sèvres 75 Paris cedex 15, France
| | - Philippe Halimi
- Service de radiologie et d'imagerie médicale de Hôpital Européen Georges Pompidou, 20-40 Rue Leblanc, 75908 Paris Cedex 15, France
| | - Michel Vidaud
- Laboratoire de Génétique Moleculaire-INSERM U745, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris V, Paris, France
| | - Jean-Louis Dufier
- Centre de Recherche Thérapeutique en Ophtalmologie, EA n°2502, Faculté de Médecine René Descartes, site Necker, 156 rue de Vaugirard 75730 Paris cedex 15, Université Paris V, Paris, France
- CHU Necker Enfants Malades, Service d'ophtalmologie, 149, rue de Sèvres 75 Paris cedex 15, France
| | - Maurice Menasche
- Centre de Recherche Thérapeutique en Ophtalmologie, EA n°2502, Faculté de Médecine René Descartes, site Necker, 156 rue de Vaugirard 75730 Paris cedex 15, Université Paris V, Paris, France
| | - Marc Abitbol
- Centre de Recherche Thérapeutique en Ophtalmologie, EA n°2502, Faculté de Médecine René Descartes, site Necker, 156 rue de Vaugirard 75730 Paris cedex 15, Université Paris V, Paris, France
- CHU Necker Enfants Malades, Service d'ophtalmologie, 149, rue de Sèvres 75 Paris cedex 15, France
| |
Collapse
|
16
|
Robert L, Menasche M, Robert AM, Renard G. Effect of High Glucose Concentration on Corneal Collagen Biosynthesis. Ophthalmologica 2006; 220:317-22. [PMID: 16954709 DOI: 10.1159/000094622] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2005] [Accepted: 12/29/2005] [Indexed: 12/17/2022]
Abstract
The effect of high glucose concentration (3 g/l) on bovine corneal total protein and collagen biosynthesis was studied, using 3H-proline incorporation in explant cultures with protein and collagen determinations. The high glucose concentration increased the incorporation of 3H-proline in total corneal proteins as well as in collagens. The specific radioactivity of stromal collagens was strongly increased in these conditions. Mannitol was used to control the osmotic effect of the high glucose concentration, both at 1 and 3 g/l concentrations. Mannitol did not increase the incorporation of 3H-proline in total proteins or collagens, but on the contrary decreased it. The high glucose concentration decreased the excretion of neosynthesized proteins and collagens in the culture medium, but did not affect the total protein or collagen content of the corneas. The strong increase in the specific radioactivity of corneal collagens in the presence of 3 g/l glucose suggests an increased turnover of collagens in diabetic corneas. The increased biosynthesis of collagens together with their decreased elimination in the extracellular compartment can create the conditions for the formation and accumulation of advanced glycation endproducts by the Maillard reaction. This can induce and stimulate the liquefaction of the vitreous body leading to sight-threatening disorders such as diabetic retinopathy, retinal detachment, glaucoma, cataract formation and age-related macular degeneration.
Collapse
Affiliation(s)
- L Robert
- Laboratoire de Recherche Ophtalmologique, Hôpital Hôtel-Dieu, Paris, France.
| | | | | | | |
Collapse
|
17
|
Boutboul S, Black GCM, Moore JE, Sinton J, Menasche M, Munier FL, Laroche L, Abitbol M, Schorderet DF. A subset of patients with epithelial basement membrane corneal dystrophy have mutations in TGFBI/BIGH3. Hum Mutat 2006; 27:553-7. [PMID: 16652336 DOI: 10.1002/humu.20331] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Epithelial basement membrane corneal dystrophy (EBMD), also known as Cogan microcystic epithelial dystrophy or map-dot-fingerprint dystrophy, is a common bilateral epithelial dystrophy. Usually, this disease is not considered to be inherited although several families with autosomal dominant inheritance have been described. We report the analysis of two families with an autosomal dominant pattern of inheritance as well as the analysis of single affected individuals; we identified two different point mutations in the TGFBI/BIGH3 genes, genes known to be associated with other corneal dystrophies. This is the first report of a molecular mutation in individuals with EBMD and it increases the spectrum of mutations in the TGFBI/BIGH3 gene. Based on our screening, up to 10% of EBMD patients could have a mutation in this gene.
Collapse
Affiliation(s)
- Sandrine Boutboul
- Centre de Recherche Thérapeutique en Ophtalmologie (CERTO), Faculté Necker-Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Mayeur H, Roche O, Vêtu C, Jaliffa C, Marchant D, Dollfus H, Bonneau D, Munier FL, Schorderet DF, Levin AV, Héon E, Sutherland J, Lacombe D, Said E, Mezer E, Kaplan J, Dufier JL, Marsac C, Menasche M, Abitbol M. Eight previously unidentified mutations found in the OA1 ocular albinism gene. BMC Med Genet 2006; 7:41. [PMID: 16646960 PMCID: PMC1468396 DOI: 10.1186/1471-2350-7-41] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/22/2005] [Accepted: 04/28/2006] [Indexed: 11/24/2022]
Abstract
Background Ocular albinism type 1 (OA1) is an X-linked ocular disorder characterized by a severe reduction in visual acuity, nystagmus, hypopigmentation of the retinal pigmented epithelium, foveal hypoplasia, macromelanosomes in pigmented skin and eye cells, and misrouting of the optical tracts. This disease is primarily caused by mutations in the OA1 gene. Methods The ophthalmologic phenotype of the patients and their family members was characterized. We screened for mutations in the OA1 gene by direct sequencing of the nine PCR-amplified exons, and for genomic deletions by PCR-amplification of large DNA fragments. Results We sequenced the nine exons of the OA1 gene in 72 individuals and found ten different mutations in seven unrelated families and three sporadic cases. The ten mutations include an amino acid substitution and a premature stop codon previously reported by our team, and eight previously unidentified mutations: three amino acid substitutions, a duplication, a deletion, an insertion and two splice-site mutations. The use of a novel Taq polymerase enabled us to amplify large genomic fragments covering the OA1 gene. and to detect very likely six distinct large deletions. Furthermore, we were able to confirm that there was no deletion in twenty one patients where no mutation had been found. Conclusion The identified mutations affect highly conserved amino acids, cause frameshifts or alternative splicing, thus affecting folding of the OA1 G protein coupled receptor, interactions of OA1 with its G protein and/or binding with its ligand.
Collapse
Affiliation(s)
- Hélène Mayeur
- EA no 2502 du ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, CEntre de Recherches Thérapeutiques en Ophtalmologie, (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, 156 rue de Vaugirard, 75015 Paris cedex, France
| | - Olivier Roche
- EA no 2502 du ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, CEntre de Recherches Thérapeutiques en Ophtalmologie, (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, 156 rue de Vaugirard, 75015 Paris cedex, France
- Service d'ophtalmologie, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris, France
| | - Christelle Vêtu
- EA no 2502 du ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, CEntre de Recherches Thérapeutiques en Ophtalmologie, (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, 156 rue de Vaugirard, 75015 Paris cedex, France
| | - Carolina Jaliffa
- EA no 2502 du ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, CEntre de Recherches Thérapeutiques en Ophtalmologie, (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, 156 rue de Vaugirard, 75015 Paris cedex, France
| | - Dominique Marchant
- EA no 2502 du ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, CEntre de Recherches Thérapeutiques en Ophtalmologie, (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, 156 rue de Vaugirard, 75015 Paris cedex, France
| | - Hélène Dollfus
- Laboratoire de diagnostic génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | | | | | | | - Alex V Levin
- Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada
| | - Elise Héon
- Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada
| | - Joanne Sutherland
- Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada
| | - Didier Lacombe
- Service de Génétique Médicale, Hôpital Pellegrin-Enfants, Bordeaux, France
| | - Edith Said
- Department of Pediatrics and Medical Genetics, St. Luke's Hospital, Gwardamangia, Malta
| | - Eedy Mezer
- Alberto Moscona Department of Ophthalmology, Rambam Health Care Campus, Haifa, Israel
| | - Josseline Kaplan
- Service de Génétique Médicale du CHU Necker-Enfants Malades, Unité INSERM 393, 149 rue de Sèvres, 75015, Paris, France
| | - Jean-Louis Dufier
- EA no 2502 du ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, CEntre de Recherches Thérapeutiques en Ophtalmologie, (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, 156 rue de Vaugirard, 75015 Paris cedex, France
- Service d'ophtalmologie, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris, France
| | - Cécile Marsac
- EA no 2502 du ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, CEntre de Recherches Thérapeutiques en Ophtalmologie, (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, 156 rue de Vaugirard, 75015 Paris cedex, France
| | - Maurice Menasche
- EA no 2502 du ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, CEntre de Recherches Thérapeutiques en Ophtalmologie, (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, 156 rue de Vaugirard, 75015 Paris cedex, France
| | - Marc Abitbol
- EA no 2502 du ministère de la Recherche, de l'Enseignement Supérieur et la Technologie, CEntre de Recherches Thérapeutiques en Ophtalmologie, (CERTO), Université René Descartes-Paris V, Faculté de Médecine René Descartes-Site Necker, 156 rue de Vaugirard, 75015 Paris cedex, France
- Service d'ophtalmologie, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris, France
| |
Collapse
|
19
|
Van Den Berghe L, Sainton K, Gogat K, Marchant D, Dufour E, Bonnel S, Gadin S, Menasche M, Abitbol M. Prosaposin Gene Expression in Normal and Dystrophic RCS Rat Retina. Invest Ophthalmol Vis Sci 2004; 45:1297-305. [PMID: 15111580 DOI: 10.1167/iovs.03-1048] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
PURPOSE To identify proteins secreted by the retinal pigment epithelium (RPE) and to analyze their cellular distribution in normal and pathologic rat retinas at various stages of eye development. METHODS A cDNA library was constructed with RNA isolated from porcine RPE sheets and screened by using the yeast signal sequence trap system. In situ hybridization, immunohistochemistry, and semiquantitative RT-PCR analysis were performed on rat retinas. RESULTS The cDNA encoding prosaposin was isolated. This is the first time this gene has been shown to be expressed in the retina. Prosaposin mRNA was detected in the rat RPE cell monolayer and in ganglion cells 14, 21, and 45 days after birth. The amount of prosaposin mRNA increased between days 14 and 45 after birth in normal retinas (rdy+), but not in the pathologic retinas (rdy-) of RCS rats. CONCLUSIONS Several techniques were used to determine the localization of prosaposin in rat retinas. The increase in the amount of prosaposin mRNA in normal retinas coincided with the maturation of photoreceptor cells and the beginning of the phagocytosis process. In addition, the RCS rdy- RPE cells, characterized by the abrogation of the ingestion phase of the photoreceptor outer segments, are deficient in prosaposin expression.
Collapse
Affiliation(s)
- Loïc Van Den Berghe
- Centre de Recherche Thérapeutique en Ophthalmologie (CERTO), Faculté de Médecine Necker Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Le Gat L, Bonnel S, Gogat K, Brizard M, Van Den Berghe L, Kobetz A, Gadin S, Dureau P, Dufier JL, Abitbol M, Menasche M. Prominent beta-5 gene expression in the cardiovascular system and in the cartilaginous primordiae of the skeleton during mouse development. Cell Commun Adhes 2004; 8:99-112. [PMID: 11936189 DOI: 10.3109/15419060109080710] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The alpha v beta (alpha(v)beta5) heterodimer has been implicated in many biological functions, including angiogenesis. We report the beta5 gene expression pattern in embryonic and foetal mouse tissues as determined by Northern blotting and in situ hybridization. During the earliest stages, beta5 mRNA is widespread in the mesoderm. During later developmental stages, it remains mostly confined to tissues of mesodermal origin, although probable inductive effects trigger shifts of beta5 gene expression from some mesenchymatous to epithelial structures. This was observed in the teeth, skin, kidneys, and gut. Of physiological importance is the beta5 labeling in the developing cardiovascular and respiratory systems and cartilages. Furthermore, early beta5 gene expression was observed within the intra- and extraembryonic sites of hematopoiesis. This suggests a major role for beta5 in the hematopoietic and angiogenic stem cells and thus in the development of the vascular system. Later, the beta5 gene was expressed in endothelial cells of the vessels developing both by angiogenesis and vasculogenesis in the lung, heart, and kidneys. Moreover, the beta5 hybridization signal was detected in developing cartilages but not in ossified or ossifying bones. beta5-Integrin is a key integrin involved in angiogenesis, vasculogenesis, hematopoiesis, and bone formation.
Collapse
Affiliation(s)
- L Le Gat
- Centre de Recherches Thérapeutique en Ophthalmologie Equipe d'accueil du Ministère de la Recherche et de l'Enseignement Supérieur, Université René Descartes, Paris V, Faculté de Médecine, Necker, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Gogat K, Le Gat L, Van Den Berghe L, Marchant D, Kobetz A, Gadin S, Gasser B, Quéré I, Abitbol M, Menasche M. VEGF and KDR gene expression during human embryonic and fetal eye development. Invest Ophthalmol Vis Sci 2004; 45:7-14. [PMID: 14691147 DOI: 10.1167/iovs.02-1096] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
PURPOSE It is important to understand the development of the normal retinal vascular system, because it may provide clues for understanding the mechanisms underlying the neovascularization associated with several retinopathies of infancy and adulthood. However, little is known about normal human ocular vascularization. VEGF is a key growth factor during vascular development and one of its receptors, KDR, plays a pivotal role in endothelial cell proliferation and differentiation. The purpose of this study was to analyze VEGF and KDR gene expression patterns during the development of the human eye during the embryonic and fetal stages. METHODS The gene expression of VEGF and KDR was analyzed by in situ hybridization in 7-week-old embryos and in 10- and 18-week-old fetuses. In addition, we performed VEGF and KDR immunohistochemistry experiments on 18-week-old fetus tissue sections. RESULTS These results clearly demonstrated that the levels of VEGF and KDR transcripts are correlated during the normal development of the ocular vasculature in humans. The complementarity between the patterns of VEGF and KDR during the early stages of development suggests that VEGF-KDR interactions play a major role in the formation and regression of the hyaloid vascular system (HVS) and in the development of the choriocapillaris. In later stages (i.e., 18-weeks-old fetuses), the expression of KDR seems to be linked to the development of the retinal vascular system. VEGF and KDR transcripts were unexpectedly detected in some nonvascular tissues-that is, in the cornea and in the retina before the development of the retinal vascular system. CONCLUSIONS The expression of VEGF and KDR correlates highly with the normal ocular vascularization in humans, but VEGF may also be necessary for nonvascular retinal developmental functions, especially for the coordination of neural retinal development and the preliminary steps of the establishment of the definitive stable retinal vasculature.
Collapse
Affiliation(s)
- Karïn Gogat
- Centre de Recherches Thérapeutiques en Ophtalmologie, Equipe d'accueil du Ministère de la Recherche et de l'Enseignement Supérieur No. 2502, Faculté de Médecine Necker, Université René Descartes Paris V, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Le Gat L, Gogat K, Bouquet C, Saint-Geniez M, Darland D, Van Den Berghe L, Marchant D, Provost A, Perricaudet M, Menasche M, Abitbol M. In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy. Gene Ther 2004; 10:2098-103. [PMID: 14595383 DOI: 10.1038/sj.gt.3302122] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Diabetic retinopathy and retinopathy of prematurity are among the leading causes of vision impairment throughout the world. Both diseases are characterized by pathological angiogenesis, which severely impairs vision. Extracellular proteinases play important roles in endothelial cell migration during angiogenesis. Amino-terminal fragment (ATF) is an angiostatic molecule that targets the uPA/uPAR system and inhibits endothelial cell migration. The angiostatic effect of ATF has been demonstrated in models of cancer, but has never been assessed in pathological retinal neovascularization. Endostatin also has angiostatic effects on tumor growth and retinal neovascularization. We used an adenoviral vector carrying the murine ATF (AdATFHSA) or endostatin gene coupled to human serum albumin (HSA) (AdEndoHSA) to increase the half-life of the therapeutic protein in the circulation. We induced retinopathy by exposing 7-day-old mice to high levels of oxygen. They were intravitreally injected with the vectors. Local injection of AdATFHSA or AdEndoHSA reduced retinal neovascularization by 78.1 and 79.2%, respectively. Thus, the adenovirus-mediated delivery of ATFHSA or EndoHSA reduces retinal neovascularization in a mouse model of hypoxia-induced neovascularization.
Collapse
Affiliation(s)
- L Le Gat
- 1CEntre de Recherches, Thérapeutiques en Ophtalmologie, EA n degrees 2502, Faculté de Médecine Necker, Paris, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Dufour EM, Nandrot E, Marchant D, Van Den Berghe L, Gadin S, Issilame M, Dufier JL, Marsac C, Carper D, Menasche M, Abitbol M. Identification of novel genes and altered signaling pathways in the retinal pigment epithelium during the Royal College of Surgeons rat retinal degeneration. Neurobiol Dis 2003; 14:166-80. [PMID: 14572440 DOI: 10.1016/s0969-9961(03)00102-5] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
Shed photoreceptor outer segments (POS) are phagocytosed by RPE cells in a circadian manner. The homozygous deletion of the c-mer gene abolishes the ingestion phase of this phagocytosis in the Royal College of Surgeons (RCS) rat strain, which in turn leads to the death of photoreceptor cells. We identified RPE transcripts for which the expression is modulated by the abrogation of POS phagocytosis. A microarray approach and the differential display (DDRT-PCR) technique revealed 116 modulated known genes, 4 modulated unknown genes, and 15 expressed sequenced tags (ESTs) corresponding to unknown genes. The microarray and DDRT-PCR analyses detected alterations in signaling pathways such as the phosphatidylinositol 3-kinase-Akt-mTOR pathway and the DLK/JNK/SAPK pathway. The abrogation of POS phagocytosis caused a decrease in endomembrane biogenesis and altered endocytosis, exocytosis, transcytosis, and several metabolic and signaling pathways in RCS RPE cells. We also found differential levels of transcripts encoding proteins involved in phagocytosis, vesicle trafficking, the cytoskeleton, retinoic acid, and general metabolism.
Collapse
Affiliation(s)
- Eric M Dufour
- CERTO, Equipe d'accueil n degrees 2502 du Ministère de la Recherche, Université René Descartes, Faculté de Médecine Necker, 156 rue de Vaugirard 75015 Paris, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Camand O, Boutboul S, Arbogast L, Roche O, Sternberg C, Sutherland J, Levin A, Héon E, Menasche M, Dufier J, Abitbol M. Mutational analysis of the OA1 gene in ocular albinism. Ophthalmic Genet 2003; 24:167-73. [PMID: 12868035 DOI: 10.1076/opge.24.3.167.15605] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Ocular albinism type 1 (OA1) is an X-linked disorder, mainly characterized by a severe reduction in visual acuity, foveal hypoplasia, nystagmus, hypopigmentation of the retina, the presence of macromelanosomes in the skin and eyes, and the misrouting of optic pathways, resulting in the loss of stereoscopic vision. We screened the OA1 gene for mutations in three unrelated Canadian and French families and in two isolated patients with OA1. We found three different missense mutations and two different nonsense mutations, three of which were novel. To date, 41 mutations (including missense mutations, insertions, and deletions) have been reported in the OA1 gene. Mutation and polymorphism data for this gene are available from the international albinism center albinism database website: http://www.cbc.umn.edu/tad/oa1map.htm.
Collapse
Affiliation(s)
- Olivier Camand
- Centre de Recherches Thérapeutiques en Ophtalmologie, Faculté de Médecine Necker, Université René Descartes and Service d'Ophtalmologie du CHU Necker Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Marchant D, Gogat K, Dureau P, Sainton K, Sternberg C, Gadin S, Dollfus H, Brasseur G, Hache JC, Dumur V, Puech V, Munier F, Schorderet DF, Marsac C, Menasche M, Dufier JL, Abitbol M. Use of denaturing HPLC and automated sequencing to screen the VMD2 gene for mutations associated with Best's vitelliform macular dystrophy. Ophthalmic Genet 2002; 23:167-74. [PMID: 12324875 DOI: 10.1076/opge.23.3.167.7880] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
We identified three novel VMD2 mutations in patients with Best's macular dystrophy. DHPLC analysis of the 11 VMD2 exons revealed abnormal profiles in exon 8. Direct sequencing showed that these abnormal profiles were due to monoallelic transitions and transversions. We also found three polymorphic sequence changes that have been reported previously and annotated to an online database (http://www.uni-wuerzburg.de/humangenetics/vmd2.html).
Collapse
Affiliation(s)
- D Marchant
- Centre de recherche thérapeutique en ophtalmologie, équipe d'accueil 2502 MENRT, Université René Descartes Paris V, Faculté de Médecine Necker-Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Abstract
The presence of fibronectin in the bovine vitreous was demonstrated by immunohistochemical procedures which showed a uniform coating of the vitreous collagen network. A fractional extraction of bovine vitreous was carried out in order to determine the distribution of fibronectin and glycosaminoglycans as related to collagen fibers. About half of total fibronectin could be extracted with aqueous buffers with increasing concentrations of KCl, part of fibronectin remained however strongly associated with the insoluble collagen network even after a final extraction with 4 M urea and 0.05 M DTT. Total extractable fibronectin was of the order of 76 micrograms per vitreous, corresponding to approximately 0.17 nM fibronectin. Total quantity of GAG-s determined as uronic acid were of the order of 2200 micrograms/vitreous corresponding approximately to 4400 micrograms disaccharide units that is to about 11 nM disaccharide units of GAG per vitreous. The persistence of fibronectin, strongly associated with the collagen fibers even after repeated KCl and urea-DTT extractions was confirmed using immuno-gold labelling of vitreous collagen fibers. Gold particle density on the collagen fibers increased with the molarity of KCl used for the extractions. These findings suggest that KCl mainly removed fiber associated components probably GAG-s, which hindered the immune recognition of fiber-bound fibronectin. The strong association of fibronectin with vitreous collagen suggested a modified model for vitreous structure taking in account the binding of fibronectin both by collagen and GAG-s.
Collapse
Affiliation(s)
- M Menasche
- Certo, faculté de médecine Necker, 75015 Paris, France
| | | | | | | |
Collapse
|
27
|
Camand O, Marchant D, Boutboul S, Péquignot M, Odent S, Dollfus H, Sutherland J, Levin A, Menasche M, Marsac C, Dufier JL, Heon E, Abitbol M. Mutation analysis of the tyrosinase gene in oculocutaneous albinism. Hum Mutat 2001; 17:352. [PMID: 11295837 DOI: 10.1002/humu.38] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Type I oculocutaneous albinism (OCA) is an autosomal recessive disorder caused by the reduction or the absence of tyrosinase (TYR) activity in melanocytes of the skin, hair and eyes. Here we report an analysis of 45 patients with OCA. We found five novel mutations in the tyrosinase gene involved in the pathogenesis of oculocutaneous albinism type IA or type IB (OCA-1A/B) in five unrelated patients. Three mutations are missense mutations (G109R, P205T and H256Y) and two are nucleotide deletions (336-337delCA and 678-680delAGG). One patient is homozygous for the previously known V275F mutation but has an extremely mild OCA phenotype and has no eye features typical of OCA. In several patients we discovered only one or even no mutation in the coding sequence of the TYR gene. Thus, this disease may also result from mutations in non coding regions of the gene or in another gene involved in the biosynthesis of melanin. Hum Mutat 17:352, 2001.
Collapse
Affiliation(s)
- O Camand
- Centre Hospitalier Régional et Universitaire Ponchaillou, Rennes, France
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Abstract
Intravitreal injections are currently used in the rat to introduce a therapeutic factor in the eye, especially for experimental treatments of retinal degenerations. The injected volume and its location can influence the quantification of results. We have investigated the quantitative effect of a single intravitreal injection in rats at different ages and for different volumes. Albinos rats aged three weeks or two months received intravitreal injections of 1, 3, 5 or 10 microl China ink. Animals were sacrificed immediately after injection, eyes were enucleated, fixated, embedded in paraffin and microtomy was performed in a sagittal plane. Regularly spaced sections were analyzed to reconstruct the vitreous and injected dye volumes. The measured vitreous volume was 6.76 +/- 0.37 mm(3) in three weeks old rats and 13.36 +/- 0.64 mm(3) in two months old rats. Mean intravitreal ink volumes immediately after injection were 0.8 mm(3) for 1 ml injections, 2 mm( 3) for 3 ml, 2.3 to 2.6 mm(3) for 5 microl and 3.2 mm(3 ) for 10 microl. The percentage of vitreous volume involved by the injection ranged from 4.4% to 33.2%. The injected volume is limited by the large lens size of the rat. Extraocular loss of injected solution increases for higher injected volumes, with larger standard deviations. In this model, the dye tends to localize behind the lens. A 3 or 5 microl volume appears to have the best reproducibility with minimum loss of solution.
Collapse
Affiliation(s)
- P Dureau
- Centre de Recherche Thérapeutique en Ophtalmologie, Université René Descartes Paris V, Faculté de Médecine Necker, Paris, France.
| | | | | | | | | |
Collapse
|
29
|
Nandrot E, Dufour EM, Provost AC, Péquignot MO, Bonnel S, Gogat K, Marchant D, Rouillac C, Sépulchre de Condé B, Bihoreau MT, Shaver C, Dufier JL, Marsac C, Lathrop M, Menasche M, Abitbol MM. Homozygous deletion in the coding sequence of the c-mer gene in RCS rats unravels general mechanisms of physiological cell adhesion and apoptosis. Neurobiol Dis 2000; 7:586-99. [PMID: 11114258 DOI: 10.1006/nbdi.2000.0328] [Citation(s) in RCA: 106] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
The RCS rat presents an autosomal recessive retinal pigment epithelium dystrophy characterized by the outer segments of photoreceptors being phagocytosis-deficient. A systematic genetic study allowed us to restrict the interval containing the rdy locus to that between the markers D3Mit13 and D3Rat256. We report the chromosomal localization of the rat c-mer gene in the cytogenetic bands 3q35-36, based on genetic analysis and radiation hybrid mapping. Using a systematic biocomputing analysis, we identified two strong related candidate genes encoding protein tyrosine kinase receptors of the AXL subfamily. The comparison of their expression patterns in human and mice tissues suggested that the c-mer gene was the best gene to screen for mutations. RCS rdy- and RCS rdy+ cDNAs were sequenced. The RCS rdy- cDNAs carried a significant deletion in the 5' part of the coding sequence of the c-mer gene resulting in a shortened aberrant transcript encoding a 20 amino acid peptide. The c-mer gene contains characteristic motifs of neural cell adhesion. A ligand of the c-mer receptor, Gas6, exhibits antiapoptotic properties.
Collapse
Affiliation(s)
- E Nandrot
- Université René Descartes, Centre de Recherches Thérapeutiques en Ophtalmologie, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Neuner-Jehle M, Berghe LV, Bonnel S, Uteza Y, Benmeziane F, Rouillot JS, Marchant D, Kobetz A, Dufier JL, Menasche M, Abitbol M. Ocular cell transfection with the human basic fibroblast growth factor gene delays photoreceptor cell degeneration in RCS rats. Hum Gene Ther 2000; 11:1875-90. [PMID: 10986560 DOI: 10.1089/10430340050129495] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Based on the K8/JTS-1-mediated transfection technique, we developed an in vivo protocol for an efficient transfer of plasmid DNA to ocular cells. As determined with condensed plasmids containing reporter genes for either beta-galactosidase (pcDNA-lacZ) or enhanced green fluorescent protein (pREP-EGFP), the immortalized human retinal epithelial cells RPE D407 and human embryonic kidney 293 cells can be transfected with typical efficiencies of 11 and 19%, respectively. Unlike 293 cells, RPE D407 cells had a reduced viability on transfection with both plasmids. In vivo, subretinal injections of DNA-K8/JTS-1 complexes revealed reporter gene expression in choroidal and RPE cells of normal pink-eyed Royal College of Surgeons (RCS) rats. The validity of this transfection technique in terms of retinal cell survival in RCS rats was then examined by using pREP-hFGF2 plasmid, which encodes the human basic fibroblast growth factor isoforms (hFGF2). Subretinal injection of pREP-hFGF2-K8/JTS-1 complexes into 3-week-old dystrophic RCS rat eyes reveals a delayed photoreceptor cell degeneration 60 days postinjection. In this case, the average analyzed field points with delayed cell dystrophy represent 14 to 17% of the retinal surface as compared with 2.6 and 4% in pREP5beta and vehicle-injected eyes, respectively. Peptide-mediated in oculo transfection thus appears to be a promising technique for the treatment of retinal cell and photoreceptor degenerations.
Collapse
Affiliation(s)
- M Neuner-Jehle
- Centre de Recherche Thérapeutique en Ophtalmologie, Equipe d'Accueil no. 2502 du Ministère de la Recherche et de l'Enseignement Supérieur, Université René Descartes Paris V, Paris, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Schorderet DF, Menasche M, Morand S, Bonnel S, Büchillier V, Marchant D, Auderset K, Bonny C, Abitbol M, Munier FL. Genomic characterization and embryonic expression of the mouse Bigh3 (Tgfbi) gene. Biochem Biophys Res Commun 2000; 274:267-74. [PMID: 10913330 DOI: 10.1006/bbrc.2000.3116] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Mutations in human BIGH3 (TGFB1), a gene identified after treatment of an adenocarcinoma cell line with TGF-beta, have been observed in patients with granular Groenouw type I, Reis-Bücklers, Thiel-Behnke, Avellino, and Lattice type I and IIIa, six autosomal dominant corneal dystrophies linked to chromosome 5q. In order to gain insight into the physiological role of this gene, we characterized the genomic structure of the mouse Bigh3 and its expression in murine embryos. The gene spans 30 kb on mouse chromosome 13 and has 17 exons. Embryonic expression of Bigh3 is observed in the mesenchyme of the first and second branchial arches as early as dpc 11.5 and is particularly strong in the mesenchyme of numerous tissues throughout all the development stages. In fetal eye, the expression is first seen at 11.5 dpc in the mesenchyme surrounding the optic stalk, extends toward the sclera and choroid by 14.3 dpc and reaches the cornea by 17.5 dpc. Because the physiological role of BIGH3/Bigh3 is still largely unknown, embryonic expression in organs like heart, vessels, and intestine may help to identify new functions which could be searched for in patients and in knock-out animal models. The characterization of the murine structure is a prerequisite for the making of such models.
Collapse
Affiliation(s)
- D F Schorderet
- Division autonome de génétique Médicale, CHUV, 1101 Lausanne, Switzerland.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Sahly I, Gogat K, Kobetz A, Marchant D, Menasche M, Castel M, Revah F, Dufier J, Guerre-Millo M, Abitbol MM. Prominent neuronal-specific tub gene expression in cellular targets of tubby mice mutation. Hum Mol Genet 1998; 7:1437-47. [PMID: 9700199 DOI: 10.1093/hmg/7.9.1437] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The tubby strain of mice exhibits maturity-onset obesity and sensory deficits in vision and hearing. The mutated gene, tub , responsible for this phenotype was identified recently, but the function of the TUB protein has not been deduced from its amino acid sequence. This prompted us to undertake expression mapping studies with the hope that they might help to elucidate the biological role of the TUB protein. We report the tub gene expression pattern in embryonic, fetal and adult mice tissues as determined by northern blots and in situ hybridization, using antisense oligonucleotidic probes. In mouse embryos, tub is expressed selectively in differentiating neurons of the ensemble of central and peripheral nervous systems, starting at 9.5 days after conception. In adult mice, tub is transcribed in several major brain areas, including cerebral cortex, hippocampus, several nuclei of the hypothalamus controlling feeding behavior, in the spiral ganglion of the inner ear and in the photoreceptor cells of the retina. These structures contain potential cellular targets of the tubby mutation-induced pathogenesis. The neuronal-specific tub gene distribution allows the establishment of a genotype-phenotype correlation in the tubby mice. This correlation is reminiscent of that observed in fat/fat mice, whose phenotype, also characterized by obesity, is caused by a null mutation in the carboxypeptidase E (CPE) gene. Our observations highlight similarities between CPE, prohormone convertases, several neuropeptides and tub gene expression patterns during embryogenesis, and may narrow down the avenues to explore in order to determine ultimately the function of the TUB protein.
Collapse
Affiliation(s)
- I Sahly
- CERTO, Faculté Necker, 156 rue de Vaugirard, 75015 Paris, France and INSERM U465, 15 rue de l'Ecole de Médecine, 75006 Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Deguine V, Menasche M, Ferrari P, Fraisse L, Pouliquen Y, Robert L. Free radical depolymerization of hyaluronan by Maillard reaction products: role in liquefaction of aging vitreous. Int J Biol Macromol 1998; 22:17-22. [PMID: 9513812 DOI: 10.1016/s0141-8130(97)00084-6] [Citation(s) in RCA: 64] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The degradation of hyaluronan was followed by viscosimetry and by HPLC in order to study the possible role of Maillard products (lysine-glucose) on the alteration of the vitreous gel in aging and diabetes. Lysine-glucose generated Maillard products produced a decrease of viscosity and of the number average molecular weight (Mn) of hyaluronan during a 1 h incubation at 37 degrees C. This effect was comparable to that produced by 1 U/ml of testicular hyaluronidase but was weaker than the effect of a Fenton-type reagent (Udenfriend's reagent). The polydispersity of hyaluronan incubated with Maillard products appeared higher than with hyaluronidase suggesting a more random reaction. Antioxydant enzymes (SOD, catalase), the iron chelators (desferrioxamine, transferrin) and the free radical scavengers (uric acid, carnosine) inhibited the degradation by Maillard products confirming its free radical nature and the intervention of trace metals. Maillard products have been detected in diabetic vitreous and may play a role in its accelerated modifications (liquefaction) in diabetes as compared to normal aging.
Collapse
Affiliation(s)
- V Deguine
- INSERM U86, Institut des Cordeliers, Paris, France
| | | | | | | | | | | |
Collapse
|
34
|
Deguine V, Menasche M, Fraisse L, Ferrari P, Pouliquen Y, Robert L. Determination of extracellular matrix degradation by free radicals using viscosity measurement of hyaluronan. Clin Chim Acta 1997; 262:147-52. [PMID: 9204217 DOI: 10.1016/s0009-8981(97)06545-5] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Affiliation(s)
- V Deguine
- INSERM U86, Institut des Cordeliers, Paris, France
| | | | | | | | | | | |
Collapse
|
35
|
Deguine V, Labat-Robert J, Ferrari P, Pouliquen Y, Menasche M, Robert L. [Aging of the vitreous body. Role of glycation and free radicals]. Pathol Biol (Paris) 1997; 45:321-330. [PMID: 9296081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
The vitreous body plays an important role in the structure and in the function of the eye. Its bio-rheological properties contribute crucially to the mechanical resistance and optical transparency of ocular tissues. The composition and structure of the vitreous body change during aging and more rapidly in diabetes. These changes may have deleterious consequences such as functional disturbances and retinal detachment. The mechanical and optical properties of the vitreous are the result of its particular macromolecular architecture composed of a hyaluronan gel supported by a fine collagen meshwork, essentially of type II and IX. These are held together by proteoglycans and by fibronectin. All these macromolecules are susceptible to free radical damage produced by UV and visible light, by metabolic processes as well as the Maillard reaction. The mechanisms by which Maillard products and free radicals play a role in the physiological or accelerated aging of the vitreous are discussed in this review.
Collapse
Affiliation(s)
- V Deguine
- Laboratoire de Biologie Cellulaire, Equipe Tissu Conjonctif, Paris, France
| | | | | | | | | | | |
Collapse
|
36
|
Deguine-Delay V, Menasche M, Schaeverbeke M, Schaeverbeke J, Pouliquen Y, Robert L. [Epigenetic mechanisms of aging: relations between Maillard reactions and radical generation]. C R Seances Soc Biol Fil 1997; 191:247-252. [PMID: 9255351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Aging is under the influence of both genetic and epigenetic factors. We are particularly interested in these latter mechanisms which play an important role in the aging of most if not all pluricellular organisms. Genetic factors on the contrary appear to differ among the species investigated. We studied two major epigenetic mechanisms: the Maillard reaction or nonenzymatic glycosylation and generation of free radicals. Using a sensitive method of free radical detection based on the degradation of hyaluronan, we could show that Maillard products are able to produce the depolymerization of this glycosaminoglycan. This may be of special importance in tissues rich in hyaluronan as the vitrous of the eye. Its degradation with age, accelerated in diabetes may well depend on such reactions, intensifyed in diabetes and involved in its complications as diabetic retinopathy.
Collapse
Affiliation(s)
- V Deguine-Delay
- Laboratoire de Biologie Cellulaire, Université Paris VII, Paris
| | | | | | | | | | | |
Collapse
|
37
|
Drubaix I, Legeais J, Savoldelli M, Menasche M, Robert L, Renard G, Pouliquen Y. 4115 Collagen synthesis in an ePTFE polymer implanted in rabbit cornea. Vision Res 1995. [DOI: 10.1016/0042-6989(95)90360-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
38
|
Deguine V, Menasche M, Fraisse L, Robert L, Pouliquen Y. P 383 Depolymerization of hyaluronan induced by glycation reaction: Possible role in vitreous liquefaction. Vision Res 1995. [DOI: 10.1016/0042-6989(95)90643-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
39
|
Menasche M, Savoldelli M, Pouliquen Y. [The keratocyte or fibroblast of the cornea: morphological and biochemical characteristics in normal stroma and a few cases of corneal dystrophies]. Pathol Biol (Paris) 1992; 40:871-8. [PMID: 1296159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Keratocytes are differentiated mesenchymal fibroblast which are specialized in the production and maintenance of the transparent corneal stroma. These elongated cells with large nuclei and scant cytoplasm produce the collages, proteoglycans, and glycoproteins which make up the stroma, as well as the enzymes involved in post-translation modifications and catabolism of these macromolecules. The characteristic morphological features and specific metabolic activity of keratocytes undergo significant changes during tissue repair and in several corneal diseases. Alterations in keratocyte biosynthetic activity, regardless of their cause, ultimately lead to fibrillar alterations responsible for a loss of corneal transparency.
Collapse
Affiliation(s)
- M Menasche
- INSERM U-86, Laboratoire de Biochimie de la Cornée, Paris, France
| | | | | |
Collapse
|
40
|
Abstract
The biosynthesis of type I, type V and type VI collagens was studied by incubation of calf corneas in vitro with [3H]proline as a marker. Pepsin-solubilized collagen types were isolated by salt fractionation and quantified by SDS/PAGE. Expressed as proportions of the total hydroxyproline solubilized, corneal stroma comprised 75% type I, 8% type V and 17% type VI collagen. The rates of [3H]proline incorporation, linear up to 24 h for each collagen type, were highest for type VI collagen and lowest for type I collagen. From pulse-chase experiments, the calculated apparent half-lives for types I, V and VI collagens were 36 h, 10 h and 6 h respectively.
Collapse
Affiliation(s)
- P Kern
- Laboratoire de Biochimie du Tissu Conjonctif, UA CNRS 1174, Faculté de Médecine, Université Paris XII, France
| | | | | |
Collapse
|
41
|
Hanna KD, Pouliquen Y, Waring GO, Savoldelli M, Cotter J, Morton K, Menasche M. Corneal stromal wound healing in rabbits after 193-nm excimer laser surface ablation. Arch Ophthalmol 1989; 107:895-901. [PMID: 2730408 DOI: 10.1001/archopht.1989.01070010917041] [Citation(s) in RCA: 159] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
An argon fluoride excimer laser (193 nm) with a moving slit delivery system was used to perform anterior myopic keratomileusis in both eyes of 24 New Zealand white rabbits. Rabbits were killed immediately after ablation and at intervals up to 100 days. By slit-lamp microscopy, four rabbits at day 100 exhibited four clear corneas and four corneas had central, spotty, subepithelial haze. Light and electron microscopy documented corneal healing. In the early stages a transient acellular zone in the anterior stroma appeared over a period of three weeks, followed by an increased number of fibrocytes. In the corneas with opacification, focal areas of 20-microns-thick subepithelial scarring were present. An unexpected finding was transient damage to posterior stromal keratocytes and endothelial cells. The endothelium produced a layer of granular material that migrated anteriorly across Descemet's membrane. Immunochemistry at day 6 showed a marked staining for collagen IV, proteoglycans, fibronectin, and laminin.
Collapse
Affiliation(s)
- K D Hanna
- Department of Ophthalmology, Hotel-Dieu Hospital, Paris, France
| | | | | | | | | | | | | |
Collapse
|
42
|
Menasche M, Robert L, Payrau P. Metabolic aspects of stromal reconstitution in trephined corneas. Exp Eye Res 1977. [DOI: 10.1016/0014-4835(77)90203-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
43
|
Menasche M, Junqua S, Payrau P, Robert L. [Regulation of the biosynthesis of macromolecules of the intercellular corneal matrix]. Pathol Biol (Paris) 1975; 23:705-9. [PMID: 177927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The influence of a 1M CaCl2 extract and of a collagenase digest of corneal stroma of the biosynthesis of the macromolecules of corneal stroma was investigated. Calf corneas were incubated "in vitro" with radioactive tracers (14C-L-proline; 3H-D-glucosamine or 35SO4) in the presence or absence of the above extracts. After incubation the corneas are submitted to a fractional extraction in order to separate the major macromolecular fractions of the stroma. An increase in incorporation of all tracers is observed in the 1M CaCl2 (CTC), TCA and urea-extracts (containing resp. the diffusible macromolecules, proteoglycans, polymeric collagen and structural glycoproteins) in the presence of the macromolecular extracts and also with the collagenase-hydrolysate of cornea. These results show the existence of a stimulation of the biosynthesis of intracellular matrix macromolecules of the cornea by corneal extracts, probably through positive "feedback" type of mechanism.
Collapse
|
44
|
Junqua S, Menasche M, Brechemier D, Pouliquen Y, Robert L. Study of morphogenetic disturbances of cornea by in vitro 14C-L-proline incorporation. Arch Ophtalmol Rev Gen Ophtalmol 1975; 35:665-8. [PMID: 130892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|